IL33 and cardiac hypertrophy: Gene ablation of IL-33 or ST2 has demonstrated that the IL-33/ST2 signaling pathway is crucial for reducing cardiac hypertrophy, ventricular chamber dilation, and cardiac fibrosis under mechanical stress (15, 23).